National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 59392-59393 [2019-23996]

Download as PDF 59392 Federal Register / Vol. 84, No. 213 / Monday, November 4, 2019 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Gastroenterology. Date: November 21–22, 2019. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Nuria E. Assa-Munt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4164, MSC 7806, Bethesda, MD 20892, (301) 451– 1323, assamunu@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Vaccines Against Microbial Diseases. Date: November 21, 2019. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Andrea Keane-Myers, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4218, Bethesda, MD 20892, (301) 435–1221, andrea.keane-myers@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–OD– 19–020: Building Interdisciplinary Research Careers in Women’s Health K12s. Date: November 21–22, 2019. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, EMNR IRG Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6182, MSC 7892, Bethesda, MD 20892, (301) 435– 2514, riverase@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cardiovascular Sciences. Date: November 21, 2019. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Chee Lim, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4128 , Bethesda, MD 20892, (301) 435–1850, limc4@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Mammalian Models for Translational Research. Date: November 21, 2019. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Regular Meeting). Contact Person: Jeffrey Smiley, Ph.D., Scientific Review Officer, Center for VerDate Sep<11>2014 20:48 Nov 01, 2019 Jkt 250001 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, (301) 594– 7945, smileyja@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Urology and Urogynecology Application Review. Date: November 21, 2019. Time: 1:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Julia Spencer Barthold, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402–3073, julia.barthold@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Cell Biology. Date: November 21, 2019. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: John Burch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 3213, MSC 7808, Bethesda, MD 20892, (301) 408– 9519, burchjb@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Tobacco Regulatory Science A. Date: November 21, 2019. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jasenka Borzan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892–7814, (301) 435–1787, borzanj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Therapeutic Approaches to Genetic Disease. Date: November 21, 2019. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Baishali Maskeri, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2022, Bethesda, MD 20892, (301) 827–2864, maskerib@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Child Psychopathology and Developmental Disabilities. PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Date: November 21, 2019. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Serena Chu. Ph.D., Scientific Review Officer, BBBP IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD 20892, (301) 500– 5829, sechu@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Electronic Nicotine Delivery Systems: Basic Mechanisms of Health Effects-PAR Panel. Date: November 21–22, 2019. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ghenima Dirami, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD 20892, (240) 498– 7546, diramig@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 29, 2019. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–23994 Filed 11–1–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\04NON1.SGM 04NON1 Federal Register / Vol. 84, No. 213 / Monday, November 4, 2019 / Notices Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; PAR–18–423: NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34). Date: November 18, 2019. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Activities, National Institutes of Health, Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 594–2242, jerkinsa@ niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: October 29, 2019. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–23996 Filed 11–1–19; 8:45 am] BILLING CODE 4140–01–P Contact Person: Lindsay M. Garvin, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Suite 7189, Bethesda, MD 20892, 301–827–7911, lindsay.garvin@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 29, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–23997 Filed 11–1–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of an Exclusive Patent License for: Autologous Cell Graft of Manufactured Retinal Pigment Epithelium Cell(s) on a Biodegradable Support Scaffold Transplanted SubRetinally for Intra-Ocular Ophthalmic Treatment of Age-Related Macular Degeneration in Humans AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health, HHS. ACTION: National Institutes of Health Notice. The National Eye Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to CellRay, LLC, (‘‘CellRay’’) located in New York, New York and its affiliates. DATES: Only written comments and/or complete applications for a license which are received by the National Cancer Institute’s Technology Transfer Center on or before November 19, 2019 will be considered. ADDRESSES: Requests for copies of the patent application, inquiries, and comments relating to the contemplated an Exclusive Patent License should be directed to: Edward Fenn., Senior Technology Transfer Manager, NCI Technology Transfer Center, 9609 Medical Center Drive, RM 1E530 MSC 9702, Bethesda, MD 20892–9702 (for business mail), Rockville, MD 20850– 9702; Telephone: (240)-276–5530; Facsimile: (240)-276–5504 Email: Tedd.Fenn@nih.gov. SUPPLEMENTARY INFORMATION: SUMMARY: National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Institutional Training Mechanism Review Committee. Date: December 13, 2019. Time: 9:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). VerDate Sep<11>2014 20:48 Nov 01, 2019 Jkt 250001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 59393 Intellectual Property • PCT Patent App. No. PCT/US2015/ 039932, filed 07/10/15 (NIH Ref. E–192– 2014–1–PCT–01); United States Patent App. No. 15/325,584, filed 01/11/17 (NIH Ref. E–192–2014–1–US–02); Australia Patent App. No. 2015287692, filed 07/10/15 (NIH Ref. E–192–2014–1– AU–03); Canada Patent App. No. 2954762, filed 07/10/15 (NIH Ref. E– 192–2014–1–CA–04); PEC Patent App. No. 15741462.4, filed 07/10/15 (NIH Ref. E–192–2014–1–EP–05); India Patent App. No. 21717003244, filed 01/30/17 (NIH Ref. E–192–2014–1–IN–06); Japan Patent App. No. 2017–501212 Filed 01/ 10/17 (NIH Ref. E–192–2014–1–JP–07); each entitled ‘‘Surgical Tool and Method for Ocular Tissue Transplantation’’ • United States Patent App. No. 62/ 215,579, filed 09/08/15 (NIH Ref. E– 212–2015–0–US–01); PCT Patent App. No. PCT/US2016/050543, filed 09/07/16 (NIH Ref. E–212–2015–0–PCT–02); United States Patent App. No. 15/ 758,314, filed 03/07/18 (NIH Ref. E– 212–2015–0–US–07); each entitled ‘‘Method for Reproducible Differentiation of Clinical-Grade Retinal Pigment Epithelium Cells’’ • United States Provisional Patent App. No. 62/419,804, filed 11/09/16 (NIH Ref. E–293–2016–0–US–01); PCT Patent App. No. PCT/US2017/060672, filed 11/08/17 (NIH Ref. E–293–2016–0– PCT–02); Australia Patent App. No. 2017359336, filed 11/08/17 (NIH Ref. E– 293–2016–0–AU–04); Canada Patent App. No. 3043174, filed 11/08/17 (NIH Ref. E–293–2016–0–CA–05); EPC Patent App. No. 17801272.0, filed 11/08/17 (NIH Ref. E–293–2016–0–EP–06); Japan Patent App. No. 2017–545900 (NIH Ref. E–293–2016–0–JP–07); United States Patent App. No. 16/348,855, filed 05/09/ 2019 (NIH Ref. E–293–2016–0–US–03); each entitled ‘‘A Surgical Clamp to Gate Large Scleral Surgery Port and Suture Alignment Tool’’; • United States Patent App. No. 62/ 453,148, filed 02/01/17 (NIH Ref. E– 094–2016–0–US–01); PCT Patent App. No. PCT/US2018/016101, Filed 01/31/ 18 (NIH Ref. E–094–2016–0–PCT–02) entitled ‘‘Devices for Tissue Cryopreservation and Recovery’’ and; United States Patent App. No. 16/ 478,093 (NIH Ref. E–094–2016–0–US– 03); Australia Patent App. No. 2018214954 filed 01/31/18 (NIH Ref. E– 094–2016–0–AU–04); Canada Patent App. No. 3048523 (NIH Ref. E–094– 2016–0–CA–05); EPC Patent App. No. 18704773.3 (NIH Ref. E–094–2016–0– EP–06); Japan Patent App. No. 2019– 538157 (NIH Ref. E–094–2016–0–JP–07); each ‘‘A Self-contained E:\FR\FM\04NON1.SGM 04NON1

Agencies

[Federal Register Volume 84, Number 213 (Monday, November 4, 2019)]
[Notices]
[Pages 59392-59393]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23996]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 59393]]


    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-18-423: NIDDK Multi-
Center Clinical Study Implementation Planning Cooperative Agreements 
(U34).
    Date: November 18, 2019.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ann A. Jerkins, Ph.D., Scientific Review 
Officer, Review Branch, Division of Extramural Activities, National 
Institutes of Health, Room 7119, 6707 Democracy Boulevard, Bethesda, 
MD 20892-5452, (301) 594-2242, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: October 29, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-23996 Filed 11-1-19; 8:45 am]
 BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.